Exposure to THC in the womb could increase the risk that genetically predisposed children are born with facial defects, according to a new rodent study published in the journal Development.
People with a history of cannabis use in their medical records appear to be at a higher risk for developing problems with anxiety, depression, and even more severe mental illnesses such as schizophrenia, according to a new study from researchers at the University of Birmingham.
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.
Robert Thomas, a leading heavy metals expert in the cannabis testing sector and principle of the consulting company Scientific Solutions, breaks down the cost differences between testing for four heavy metals and for fifteen.
Ketamine alone may be just as effective as ketamine combined with traditional antidepressants for tackling treatment-resistant depression, a new study has found.
Many hemp farmers in Oregon are growing something a bit stronger than advertised, according to a new report from state regulators.
The affected marijuana material ended up in several products, including bud, pre-packaged bud, and pre-roll joints.